Springbok Prop Asenathi Ntlabakanye Faces Disciplinary Hearing Over Dual Anti Doping Allegations

Springbok Asenathi Ntlabakanye sidelined for Dragons clash as he faces a disciplinary hearing over medical substance use and anti doping violations.

By: AXL Media

Published: Mar 23, 2026, 9:13 AM EDT

Source: Information for this report was sourced from Rugby365

Legal Proceedings Side-line Lions Key Forward

The Johannesburg based Lions will navigate their next domestic fixture without the presence of Asenathi Ntlabakanye as the prop prepares to address formal doping charges this week. The disciplinary hearing, which is scheduled to span three days, effectively removes the Springbok from the team's training environment and the Round 14 selection pool. This development follows an extended period of speculation after an initial adverse finding was reported during a random screening process late last year.

Complex Charges Involving Specified and Unspecified Substances

The South African Institute for Drug Free Sport has issued a formal charge letter identifying two distinct violations. The first involves anastrozole, which is classified as a specified substance and is generally considered non performance enhancing in a direct athletic context. The second charge, however, involves DHEA, an unspecified and performance enhancing substance that was reportedly disclosed by the player himself during the investigative process. This duality of charges creates a complex legal landscape for the independent panel to adjudicate within the framework of global anti doping codes.

Medical Authorization as a Central Defense Pillar

The defense strategy for the 26 year old athlete appears to rely heavily on the role of professional medical practitioners. Official statements indicate that the substances in question were prescribed by a specialist physician in early 2025 for legitimate medical reasons. Furthermore, the treatment was reportedly conducted under the direct supervision of a doctor appointed specifically to manage the affairs of professional rugby players. The player's representatives argue that he acted in good faith and followed all prescribed industry protocols without seeking an unfair competitive advantage.